Loading
Life sciences · Journal article
Reports of Practical Oncology & Radiotherapy · October 2, 2026
No summary has been generated for this record yet. What follows is drawn from its source metadata only.
Journal article.
No findings were extractable from the material analysed.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
This record has not been graded across any dimension yet. Treat the label above as provisional and read the source.
What is missing. This record has no bottom line, key findings, reported figures, evidence dimensions. That is a gap in the analysis, not a judgement about the study.
The most important treatment modality, and thus the treatment of choice, for early-stage cervical cancer (CC) is radical surgery. Based on the subsequent pathological findings, early-stage CCs are classified as low risk (LR), intermediate risk (IR), or high risk (HR). Adjuvant therapy is guided by assignment to one of the above-mentioned risk groups. Adjuvant therapy is not indicated for LR stages. The indication for adjuvant radiotherapy (RT) in patients with IR early-stage CC is based on the presence of the so-called Sedlis criteria from a single prospective randomised study published as early as 1999. With improvements in pre-operative diagnosis and surgical techniques, efforts are underway to de-escalate adjuvant therapy in an attempt to minimise overall treatment related morbidity. The indication for adjuvant RT in IR early-stage CC is therefore not based on a phase 3 randomised trial in the context of current diagnostic and therapeutic practices. For the time being, a shared treatment decision-making approach should be employed. The same essentially applies to the inclusion of adjuvant vaginal brachytherapy (VBT) in the treatment regimen. In this case, only a limited number of retrospective studies are available. In cases where vaginal resection margins are positive or close to the margin, it is generally recommended.